Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Cassidy

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Cancer Research|March 11, 2010
Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)Jonathan R Dry, Sandra Pavey, Christine A Pratilas, et al.
Nature Communications|January 4, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesRachel H Clare, Catherine Bardelle, Paul Harper, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Cancer Research|March 11, 2010
Transcriptional pathway signatures predict MEK addiction and response to selumetinib (AZD6244)Jonathan R Dry, Sandra Pavey, Christine A Pratilas, et al.
Nature Communications|January 4, 2019
Industrial scale high-throughput screening delivers multiple fast acting macrofilaricidesRachel H Clare, Catherine Bardelle, Paul Harper, et al.
Journal of Medicinal Chemistry|February 8, 2019
Boron-Pleuromutilins as Anti- Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic FilariasisRobert T Jacobs, Christopher S Lunde, Yvonne R Freund, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 9, 2019
AWZ1066S, a highly specific anti-<i>Wolbachia</i> drug candidate for a short-course treatment of filariasisW David Hong, Farid Benayoud, Gemma L Nixon, et al.
Pageof 6